Vitamin K2 Protects Against Glucocorticoid-Induced Osteoporosis by Activating the NRF2/FSP1 Pathway to Inhibit Osteoblast Ferroptosis
Zhichao Zhang, Xing Rong, Qinghua Ren, Yuying Kou, Jie Guo, Minqi Li · 2025
Read Vitamin K2 Protects Against Glucocorticoid-Induced Osteoporosis by Activating the NRF2/FSP1 Pathway to Inhibit Osteoblast Ferroptosis by Zhichao Zhang, Xing Rong, Qinghua Ren, Yuying Kou, Jie Guo, Minqi Li (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743465.txt.
Description
Zhichao Zhang and co-authors test vitamin K2 against steroid-driven bone loss in a 2025 study. Long steroid use is the top cause of secondary osteoporosis. Oxidative stress and weak bone building drive the loss. Vitamin K2 fights oxidation and aids bone formation, yet its role here was unclear.
A steroid drug induced bone loss in mice, tracked by fine CT scans and tissue stains. Vitamin K2 partly saved bone mass and bone cell activity. In cell tests it guarded cell powerhouses and curbed lipid damage. The benefit ran through a defense pathway that blocks a form of iron-driven cell death in bone cells. The work nominates a cheap protector for steroid users.
Catalog record
| CREATOR | Zhichao Zhang, Xing Rong, Qinghua Ren, Yuying Kou, Jie Guo, Minqi Li |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |